Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias | Phase 4 | ClinicalTrials |
| Breast Neoplasms; Diarrhea | Phase 2 | ClinicalTrials |
| Arterial Occlusive Diseases; Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Coronary Disease; Heart Diseases; Intracranial Arteriosclerosis; Myocardial Ischemia | Phase 3 | ClinicalTrials |
| Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Heart Diseases; Ischemia; Myocardial Ischemia | Phase 3 | ClinicalTrials |
| Porphyria, Erythropoietic; Porphyrias; Protoporphyria, Erythropoietic | Phase 2/Phase 3 | ClinicalTrials |
Related Entries
CONTENTS